MedTrace Logo

Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden

NCT02592265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 233

Last updated 2024-09-19

No results posted yet for this study

Summary

The objective of this study is to measure economic burden of Multiple Sclerosis (MS) from a new point of view that includes consequences of disability on Quality Of Life (QOL), social participation and capabilities of patients and caregivers. To the investigators' knowledge, there is currently no data including intangible costs related to caregivers and calculating the overall economic cost of Multiple Sclerosis, particularly, in France.

Conditions

  • Multiple Sclerosis
  • Physical Disability
  • Economic Burden
  • Social Interaction
  • Capability
  • Quality of Life

Sponsors & Collaborators

  • Université de Lille

    collaborator OTHER

  • Région Nord-Pas de Calais, France

    collaborator OTHER

  • La Ligue Française Contre la Sclérose en Plaques

    collaborator OTHER

  • Novartis

    collaborator INDUSTRY

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Arnaud KWIATKOWSKI · Groupement des Hôpitaux de l'Institut Catholique de Lille

  • Amélie LANSIAUX · Groupement des Hôpitaux de l'Institut Catholique de LilleGroupement des Hôpitaux de l'Institut Catholique de Lille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-08-31
Completion
2016-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02592265 on ClinicalTrials.gov